Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/1996
11/28/1996WO1996037209A1 Use of flavanolignanes for the preparation of medicaments with antiproliferative activity in uterus, ovary and breast
11/28/1996WO1996037205A1 Remedy for endotoxinemia and multiple organ failure induced thereby
11/28/1996WO1996037204A1 Inhibitors of farnesyl-protein transferase
11/28/1996WO1996037201A2 METHODS AND COMPOSITIONS FOR INHIBITING 5α-REDUCTASE ACTIVITY
11/28/1996WO1996037197A1 Use of tropolone derivatives as inhibitors of the enzyme inositol monophosphatase
11/28/1996WO1996037187A1 Cosmetic or dermatological preparations containing phytic acid
11/28/1996WO1996025931A3 Use of fused benzothiazoles as neuroprotectants
11/28/1996WO1996023883A3 Modified ligands for receptor tyrosine kinases
11/28/1996DE19519979A1 Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln New quinoxalinedione derivatives, their preparation and use in medicaments
11/28/1996DE19518845A1 Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Phytinsäure Cosmetic or dermatological preparations containing phytic acid
11/28/1996CA2222055A1 Multimeric proteins
11/28/1996CA2222041A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
11/28/1996CA2222034A1 2-amino-benzoxazinones for the treatment of viral infections
11/28/1996CA2221980A1 Isoxazoline and isoxazole derivatives as integrin receptor antagonists
11/28/1996CA2221701A1 Inhibitors of farnesyl-protein transferase
11/28/1996CA2221695A1 New quinoxalinedione derivatives, their production and use in pharmaceutical agents
11/28/1996CA2221236A1 Methods and compositions for inhibiting 5.alpha.-reductase activity
11/28/1996CA2220837A1 Compositions of interleukin and pyrimidine nucleosides
11/28/1996CA2218759A1 Novel variants of apolipoprotein a-i
11/27/1996EP0744397A2 Fluorophenyl substituted alkenyl carboxylic acid guanidines as Na+/H+ exchange inhibitors, process for their preparation, their use as medicinal or diagnostic agent as well as a medicament containing them
11/27/1996EP0744176A2 Methods for inhibiting bone loss
11/27/1996EP0743984A1 Nucleic acid-containing composition, its preparation and use
11/27/1996EP0743949A1 Process for producing endotoxin-free or endotoxin-poor nucleic acids and/or oligonucleotides for gene therapy
11/27/1996EP0743944A1 Azacyclic derivatives
11/27/1996EP0743943A1 Pyridyl imidazole derivatives and processes for the preparation thereof
11/27/1996EP0743939A1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists
11/27/1996EP0743938A1 Substituted spiro compounds for the treatment of inflammation
11/27/1996EP0743859A1 Chimeric oligonucleoside compounds
11/27/1996EP0743858A1 Antioxidants and intracellular glutathione raising agents for therapeutic treatments
11/27/1996EP0743855A1 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/nmda receptor
11/27/1996EP0743853A1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
11/27/1996CN1136826A Recombinant P53 adenovirus method and compositions
11/27/1996CN1136808A Pseudodipeptide product having imidazole grouping and applications
11/27/1996CN1136807A N-substituted azabicycloheptane derivatives their preparation and use
11/27/1996CN1136806A Prolyl endopeptidase inhibitors
11/27/1996CN1136568A New heterocyclic spiro compounds, process for preparation thereof, and pharmaceutical compositions containing them
11/27/1996CN1136566A Indole derivatives
11/27/1996CN1136565A Indole derivatives
11/27/1996CN1136432A Indole derivatives
11/27/1996CN1033365C Preparing method for lipides composition containing scutellaria compound
11/27/1996CN1033358C Prodn. method of nutriment from "Xiangyu mushroom"
11/26/1996US5578724 Process for preparation of benzo[f]quinolinones
11/26/1996US5578708 Derived from bones of mammals including mice and humans; diagnosis and therapy for bone metabolic diseases
11/26/1996US5578707 Soluble interferon-gamma receptor fragment
11/26/1996US5578639 PLA2 inhibitors and their use for inhibition of intestinal cholesterol absorption
11/26/1996US5578634 1H-indole-3-acetic acid hydrazide sPLA2 inhibitors
11/26/1996US5578631 Methods of combating Pneumocystis carinii pneumonia and compounds useful therefor
11/26/1996US5578617 Method and compositions for treating age related disorders
11/26/1996US5578616 Antiinflammatory agents, antiallergens, treatment for gastrointestinal and cardiovascular disorders
11/26/1996US5578612 Indole derivatives
11/26/1996US5578611 Antitumor agents and prostate tumor detection by binding human alpha-adrenergic receptor and histamine h1 receptors
11/26/1996US5578608 Hiv protease inhibitor
11/26/1996US5578603 Treatment for alzheimer*s disease, gaastrointrestinal disorders
11/26/1996US5578588 Nasal administration of a precursor
11/26/1996US5578571 Cytostatic or cytotoxic combination of active substances for use in therapeutic procedures
11/26/1996US5578569 Method of increasing bone growth
11/26/1996US5578305 Methods and preparations for preventing adhesions to organs and parts of organs
11/26/1996CA2078287C Nitroxides as protectors against oxidative stress
11/26/1996CA2033448C Antiherpes compositions and method of use
11/24/1996CA2177115A1 Methods for inhibiting bone loss
11/21/1996WO1996036720A1 Recombinant heregulins and their biological functions upon receptor activation
11/21/1996WO1996036713A2 Eck receptor ligands
11/21/1996WO1996036710A1 Bmp-15 compositions
11/21/1996WO1996036709A1 Transforming growth factor alpha hii
11/21/1996WO1996036698A1 Mch2, AN APOPTOTIC CYSTEINE PROTEASE, AND COMPOSITIONS FOR MAKING AND METHODS OF USING THE SAME
11/21/1996WO1996036638A1 Xanthines and their therapeutic use
11/21/1996WO1996036630A1 Tetralin compounds with mdr activity
11/21/1996WO1996036626A1 Cyclohexyl dihydrobenzofuranes
11/21/1996WO1996036625A1 Phenyl dihydrobenzofuranes
11/21/1996WO1996036623A1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors
11/21/1996WO1996036620A1 Diaryldiamine derivatives and their use as delta opioid (ant)-agonists
11/21/1996WO1996036617A1 Substituted oxazoles for the treatment of inflammation
11/21/1996WO1996036608A1 α,β-UNSATURATED KETONE DERIVATIVES
11/21/1996WO1996036363A1 Method for pharmaceutical delivery
11/21/1996WO1996036362A1 Compositions containing nucleic acids and ligands for therapeutic treatment
11/21/1996WO1996036350A1 Use of il-13 to induce 15-lipoxygenase
11/21/1996WO1996036336A1 New pharmacological use of aii-receptor antagonists
11/21/1996WO1996036334A1 Use of calcium intracellular store inactivators and formulations thereof as cell growth inhibitors
11/21/1996WO1996036222A2 Improved method for controlling ectoparasites
11/21/1996WO1996030042A3 Methods of treating inflammation and compositions therefor
11/21/1996WO1996026712A3 Use of angiogenesis suppressors for inhibiting hair growth
11/21/1996CA2221692A1 Substituted oxazoles for the treatment of inflammation
11/21/1996CA2221449A1 Use of il-13 to induce 15-lipoxygenase
11/21/1996CA2221380A1 Diaryldiamine derivatives and their use as delta opioid (ant)-agonists
11/21/1996CA2221357A1 Phenyl dihydrobenzofuranes
11/21/1996CA2221351A1 Cyclohexyl dihydrobenzofuranes
11/21/1996CA2221269A1 Compositions containing nucleic acids and ligands for therapeutic treatment
11/21/1996CA2220010A1 Bmp-15 compositions
11/21/1996CA2219752A1 Tetralin compounds with mdr activity
11/21/1996CA2219395A1 New pharmacological use of aii-receptor antagonists
11/21/1996CA2219129A1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors
11/21/1996CA2218548A1 Xanthines and their therapeutic use
11/21/1996CA2217020A1 Recombinant heregulins and their biological functions upon receptor activation
11/20/1996EP0743320A2 Acyl guanidine and amidine prodrugs
11/20/1996EP0743319A1 Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ace and nep
11/20/1996EP0743312A1 Spiroheterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
11/20/1996EP0743304A1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones
11/20/1996EP0743302A2 Sulfonamide fibrinogen receptor antagonists
11/20/1996EP0743301A2 Benzoylguanidines containing fluorine
11/20/1996EP0743063A1 Use of derivatives of alpha-aminomethyl-3,4-dichlorobenzyl thioacetamide for the preparation of a medicament inhibiting the recapture of dopamine and compounds for this use
1 ... 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 ... 1564